Factors influencing the use of biologic therapy and adoption of treat-to-target recommendations in current European rheumatology practice

Peter C Taylor1 Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK, [email protected]Correspondence[email protected]

Rieke Alten2 Department of Internal Medicine II, Rheumatology, Clinical Immunology, and Osteology, Schlosspark Klinik, University Medicine Berlin, Berlin, Germany

Juan J Gomez Reino3 Experimental and Observational Rheumatology and Rheumatology Unit, Fundacion Ramon Dominguez and Rheumatology, Hospital Clinico Universitario, Santiago de Compostela, Spain

Roberto Caporali4 Division of Rheumatology, IRCCS Foundation Policlinico S. Matteo, University of Pavia, Pavia, Italy

Philippe Bertin5 Service de Rhumatologie, CHU Dupuytren, Limoges, France

Emma Sullivan6 Real-World Evidence and Epidemiology, Adelphi Real World, Bollington, UK

Robert Wood6 Real-World Evidence and Epidemiology, Adelphi Real World, Bollington, UK

James Piercy6 Real-World Evidence and Epidemiology, Adelphi Real World, Bollington, UK

Radu Vasilescu7 Medical Affairs, International Developed Markets, Pfizer, Brussels, Belgium

Dean Spurden8 Health Economics and Outcomes Research, Pfizer Ltd, Tadworth, UK

Jose Alvir9 Statistical Research and Data Science Center, Global Product Development, Pfizer Inc, New York, NY, USA

Miriam Tarallo10 Patient and Health Impact, Pfizer Italia Srl, Rome, Italy

show all

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Factors influencing the use of biologic therapy and adoption of treat-to-target recommendations in current European rheumatology practice

Articles from other publishers (3)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Factors influencing the use of biologic therapy and adoption of treat-to-target recommendations in current European rheumatology practice

Citations (3)

Articles from other publishers (3)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date